Targeting glioblastoma with UniPR1331, a new and stable bioavailable small molecule inhibiting Eph–ephrin interaction: In vitro and in vivo evidence. (December 2016) - Festuccia, C.; Giorgio, C.; Gravina, G.L.; Castelli, R.; Vacondio, F.; Rusnati, M.; Chiodelli, P.; Barocelli, E.; Lodola, A.; Tognolini, M.